NASDAQ:POAI Predictive Oncology (POAI) Stock Price, News & Analysis $7.44 -0.12 (-1.59%) As of 11/4/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsNews and TrendsSEC Filings About Predictive Oncology Stock (NASDAQ:POAI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Predictive Oncology alerts:Sign Up Key Stats Today's Range$7.26▼$7.8750-Day Range$7.44▼$12.9952-Week Range$0.71▼$16.54Volume152,001 shsAverage Volume473,545 shsMarket Capitalization$25.25 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Predictive Oncology Inc. (NASDAQ: POAI) is a biotechnology company focused on applying artificial intelligence, machine learning, and laboratory-based cancer research to drug discovery and precision oncology. The company uses tumor samples and related biological data to study how individual cancers may respond to potential treatments. Its technology offerings have included AI-enabled platforms designed to analyze cancer data, identify potential drug candidates, and predict treatment responses. Predictive Oncology has also provided tumor profiling, drug-screening, biobanking, and contract research services to pharmaceutical, biotechnology, and academic customers. The company has developed its operations through acquisitions and affiliated businesses, including Helomics, a precision oncology company specializing in patient-derived tumor models and drug-response testing. Predictive Oncology is headquartered in the United States and serves customers in the life sciences and healthcare research sectors. The company was formerly known as Skyline Medical before adopting the Predictive Oncology name as its business shifted toward artificial intelligence and cancer research.AI Generated. May Contain Errors. Read More Receive POAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Predictive Oncology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. POAI Stock News HeadlinesPredictive Oncology announces name change to Axe ComputeDecember 12, 2025 | msn.comPredictive Oncology rebrands to Axe Compute Inc.December 11, 2025 | msn.comWhat Elon Musk's Cybercab Reveal Could Mean for InvestorsJeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He points to a new AI project tied to Musk's Cybercab reveal. Brown says Musk has opened major investment windows before, with PayPal, Tesla, and SpaceX marking milestones in tech history. He believes a fourth may open by October 30.November 5 at 1:00 AM | Brownstone Research (Ad)Predictive Oncology Regains Nasdaq ComplianceDecember 2, 2025 | tipranks.comPredictive Oncology regains compliance with Nasdaq minimum stockholder equityDecember 2, 2025 | msn.comPredictive Oncology Regains Compliance with Nasdaq's Minimum Stockholders' Equity RequirementDecember 2, 2025 | markets.businessinsider.comPredictive Oncology Regains Nasdaq Compliance with InvestmentsNovember 20, 2025 | tipranks.comPredictive Oncology Expands into Digital Asset ManagementNovember 20, 2025 | msn.comSee More Headlines POAI Stock Analysis - Frequently Asked Questions How have POAI shares performed this year? Predictive Oncology's stock was trading at $7.15 at the beginning of the year. Since then, POAI shares have increased by 4.1% and is now trading at $7.44. How were Predictive Oncology's earnings last quarter? Predictive Oncology Inc. (NASDAQ:POAI) issued its quarterly earnings data on Friday, November, 14th. The medical instruments supplier reported ($4.52) earnings per share for the quarter, missing the consensus estimate of ($1.35) by $3.17. The medical instruments supplier had revenue of $3.62 thousand for the quarter, compared to the consensus estimate of $1.50 million. Predictive Oncology had a negative net margin of 5,065.23% and a negative trailing twelve-month return on equity of 732.73%. Read the conference call transcript. When did Predictive Oncology's stock split? Predictive Oncology's stock reverse split on the morning of Tuesday, September 30th 2025.The 1-15 reverse split was announced on Thursday, September 25th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 29th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. How do I buy shares of Predictive Oncology? Shares of POAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Predictive Oncology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Predictive Oncology investors own include FuelCell Energy (FCEL), Tesla (TSLA), NVIDIA (NVDA), Plug Power (PLUG), AMC Entertainment (AMC), Bionano Genomics (BNGO) and Lithium Americas (LAC). Company Calendar Last Earnings11/14/2025Today11/05/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorTechnology Industry IT Services Sub-IndustryInternet Services & Infrastructure Current SymbolNASDAQ:POAI CIK1446159 Webwww.precisiontherapeutics.com Phone(651) 389-4800FaxN/AEmployees30Year Founded2002Profitability EPS (Trailing Twelve Months)($13.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$12.66 million Net Margins-5,065.23% Pretax Margin-5,082.34% Return on Equity-732.73% Return on Assets-235.55% Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual Sales$1.66 million Price / Sales15.17 Cash FlowN/A Price / Cash FlowN/A Book Value($0.46) per share Price / Book-16.17Miscellaneous Outstanding Shares3,394,000Free Float3,353,000Market Cap$25.25 million OptionableNot Optionable Beta1.35 Social Links 7 Energy Stocks to Buy and Hold ForeverOil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.Get This Free Report This page (NASDAQ:POAI) was last updated on 11/4/2026 by MarketBeat.com Staff. From Our PartnersThe 401k Email 70 Million Investors Might DeleteAn email announcing a new 401k investment option is headed to roughly 70 million inboxes. Most recipients will...Brownstone Research | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThis little-known fund tracks gold and pays out weeklyA little-known $15 fund tied to gold could pay you cash every Friday, no mining stock required. In one rece...Investors Alley | Sponsored$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that l...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Predictive Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Predictive Oncology With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.